The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Emory researchers find race and gender gaps in treatment of heart attack

NEW ORLEANS If you are a woman suffering a heart attack (also called a myocardial infarction or MI), will you receive the same care as a man? If you are an African-American MI patient, will you get the optimum treatment offered your white counterpart?

In research presented here today at the American College of Cardiology's 53rd Scientific Sessions, Emory researchers conclude the answers to these questions are troubling. Despite the fact that there has been increasing attention to sex and race related disparities in the management of myocardial infarction over the past decade, the scientists say there are gender and racial gaps in the U.S. between heart attacks therapies white men receive and those treatments offered to women and blacks.

The Emory Heart Center researchers studied the records of 672,817 white and black patients younger than 75 years of age from the National Registry of Myocardial Infarction. They examined differences from 1994 to 2002 by sex and race in the use of recommended treatments and procedures for MI (including reperfusion therapy, aspirin, beta blockers, and coronary angiography) among patients who were ideal candidates for each of these. They also examined differences in revascularization procedures among patients who had received coronary angiography.

"We found that African-American women and men have continued to receive less aggressive management than white men after myocardial infarction," says Emory investigator Viola Vaccarino MD, Ph.D., lead author of the study.

Gender and racial differences were greater for reperfusion therapy, coronary angiography and coronary artery bypass graph (CABG) surgery than for other MI treatments -- and black women were found to have the lowest use of these interventions. Treatment differences between white women and white men tended to be small, with the exception of CABG.

Dr. Vaccarino says the researchers were surprised to discover there has been no trend
'"/>

Contact: Sherry Baker
emoryheartnews@aol.com
404-377-1398
Emory University Health Sciences Center
9-Mar-2004


Page: 1 2

Related medicine news :

1. Emory Study finds HIV is not an independent risk factor for severe heart disease
2. Emory cardiologists present research at AHA scientific sessions in New Orleans, Nov. 7 - 10
3. Emory study finds mental health and heart disease tightly linked
4. Emory conference to educate health professionals about metabolic syndrome
5. Emory researcher examines effects of antiepileptic drugs on pregnant women and their offspring
6. Emory, GlaxoSmithKline, NIMH enter public-private partnership to develop new drugs for depression
7. Emory and CDC scientists explore why most breastfed infants of HIV-positive mothers resist infection
8. Emory scientists find marker for long-term immunity
9. Emory scientists find oral tetrahydrobiopterin can reduce high blood pressure
10. Emory scientists link atrial fibrillation with decrease in nitrous oxide
11. Immune memory from smallpox vaccination lasts more 50 years, according to Emory research

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Emory researchers find race and gender gaps treatment heart attack

(Date:11/8/2009)...ire/ -- Pharmaceutical Research and Manufacturers ...on released the following statement regarding the ...pointed, but not surprised by today,s vote -- an u...ans as well as nearly half of the members of the U... bill. ,, "While well intentioned, the bill -- ...
(Date:11/8/2009)...Care Reform Bill ,, Critical legislation woul...ericans ,, BALTIMORE, Nov. 7 /PRNewswire-USNew...se of Representatives passed critical health care ...for seniors and end discrimination by insurance co...ffordable health coverage. ,, The Affordable He...
(Date:11/7/2009).../ -- The American Medical Association (AMA) proudl...Family Violence Prevention Fund, with the Citation...l policy-making meeting. The Citation for Disting...of Delegates bestows on a non-physician. ,, (...209/AMALOGO ) ,, "Ms. James has worked selfle...
(Date:11/7/2009)...sponsibility to vigorously oppose abortion in heal...HINGTON, Nov. 7 Amer...e following statement on the news that Cardinal Ju...fordable Health Care for America Act (H.R. 3962), ...r abortion is voted upon. ,, "Our Catholic bis...
(Date:11/7/2009)...rebel, expert says , , SATURDAY, Nov. 7 (H...badly if their parents expect them to, a new U.S. ...imply being realistic might actually contribute to...psychology professor at Wake Forest University and... release. "Negative expectations on the part of bo...
Breaking Medicine News(10 mins):Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors Family Violence Prevention Expert 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2
(Date:11/6/2009)...wire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulleti...lanta-based, biopharmaceutical company developing ... Immunodeficiency Virus) and other infectious agen...al results and provided an operational update. ,...utive Officer commented, "We are pleased with our ...
(Date:11/6/2009)...PRNewswire/ -- , - Trial Will Compare NXL...tment of Multi-Resistant Staphylococcus Aureus (MR...armaceutical company focused on the discovery and,...ome the significant global,problem of microbial re...ral,antibacterial NXL103 (flopristin/linopristin),...
(Date:11/5/2009)... Helix BioPharma Corp. (...at its Phase II trial of Topical Interferon Alpha-...s completed patient enrollment, with the required ... The double-blind and placebo-controlled Phase II ...nd Sweden. Patients participating in the trial se...
Breaking Medicine Technology:GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 3Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 4Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 5Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 6Team24 News Article New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies like Team24 52479 1Team24 News Article New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies like Team24 52479 2Team24 News Article New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies like Team24 52479 3Burner Balm Gets International Attention 52477 1Burner Balm Gets International Attention 52477 2Takeda Provides Update on the Investigational Fixed Dose Combination of alogliptin and ACTOS 28R 29 28pioglitazone HCl 29 4769 1Takeda Provides Update on the Investigational Fixed Dose Combination of alogliptin and ACTOS 28R 29 28pioglitazone HCl 29 4769 2Takeda Provides Update on the Investigational Fixed Dose Combination of alogliptin and ACTOS 28R 29 28pioglitazone HCl 29 4769 3
Other News:
...unces nationwide initiative to boost awareness of....arcolepsy Network announced today that it.is joini..."Wake Up to.Narcolepsy," an educational initiative...narcolepsy and its treatment. An estimated 125,00...
...em, N.C. -- Researchers at Wake Forest University ...to report the successful use of.magnetic resonance...n blood.vessels leading to the heart. This is the ...nd determine if they require treatment... M...
...nts may face an increased risk of depression as a ...pplies of estrogen, according to the.results of a ...pital, Boston. .."Dysphoria, insomnia, and hot fla...ancer treatment induced estrogen deficiency," says...
... 1999 -- America's growing use of depression-treat...epressants the biggest contributors to a.record-se...nt last year,.according to a study by the country'...press Scripts, Inc. ..Not everyone was hit by the...
health news:Narcolepsy network issues national 'wake up' call 2health news:Narcolepsy network issues national 'wake up' call 3health news:Wake Forest researchers develop new technique to diagnose narrowed heart,arteries 2health news:Breast cancer patients face increased depression 2health news:Depression-treating drugs lead record-setting pharmacy benefit cost rise -- Total increase lower when pharmacy benefit actively managed 2health news:Depression-treating drugs lead record-setting pharmacy benefit cost rise -- Total increase lower when pharmacy benefit actively managed 3health news:Depression-treating drugs lead record-setting pharmacy benefit cost rise -- Total increase lower when pharmacy benefit actively managed 4
...An inhaled anti-rejection drug can dramatically im...to a study conducted at the University of Pittsbur... at the University of Maryland in Baltimore. The r...2, 2006 edition of the New England Journal of Medi...
...Eating a very low-calorie yet nutritionally balanc...ction in members of an organization called the Cal...ton University School of Medicine in St. Louis fou... much younger people. The researchers report their...
The human body contains many metals, from the iron in hemoglobin to the calcium in bones. Other metals, usually in trace amounts, participate in many metabolic and degenerative processes. The recent i
...This month, the medical humanitarian organisation,...n initiative to help vulnerable people to access h...n why such a scheme is needed, while an editorial ...owards marginalised people.......Providing health ...
health news:Study shows inhaled medicine improves survival for lung transplant patients 2health news:Study shows inhaled medicine improves survival for lung transplant patients 3health news:Study shows inhaled medicine improves survival for lung transplant patients 4health news:Caloric restriction appears to prevent primary aging in the heart 2health news:Caloric restriction appears to prevent primary aging in the heart 3health news:Caloric restriction appears to prevent primary aging in the heart 4